Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000032.xml
Klinische Neurophysiologie 2011; 42(1): 1-7
DOI: 10.1055/s-0030-1266066
DOI: 10.1055/s-0030-1266066
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York
Chronische Immunneuropathien – Klinisches Spektrum, Diagnostik, Therapie
Chronic Immune-Mediated Neuropathies – Clinical Finding, Diagnosis, TherapyFurther Information
Publication History
Publication Date:
04 March 2011 (online)
Lernziele
Kenntnisse über
Diagnose, Differenzialdiagnose und Therapie der chronisch inflammatorischen demyelinisierenden Polyneuropathie Diagnose, Differenzialdiagnose und Therapie der multifokalen motorischen Neuropathie
Literatur
- 1 Dyck P J, Lais A C, Ohta M et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975; 50 621-637
- 2 Saperstein D S, Katz J S, Amato A A et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001; 24 311-324
- 3 Van den Bergh P YK, Hadden R DM, Bouche P et al. European Federation of Neurological Societies / Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Europ J Neurol. 2010; 17 356-363
- 4 Saperstein D S, Barohn R J. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Reports. 2003; 3 57-63
- 5 McLeod J G, Pollard J D, Macaskill P et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. 1999; 46 910-913
-
6 http://www.dgn.org/component/content/article/18-leitlinien/451-leitlinien-der-dgn-diagnostik-bei-polyneuropathien.html?q=cidp
- 7 Mehndiratta M M, Hughes R AC. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2002; 3 CD002062
- 8 Lozeron P, Nahum L, Lacroix C et al. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002; 249 569-575
- 9 Roth G, Rohr J, Magistris M R et al. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol. 1988; 25 416-423
- 10 Parry G L, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988; 11 103-107
- 11 Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005; 31 663-680
- 12 Meuth S G, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. Eur Neurol. 2010; 63 193-204
- 13 Katz J S, Wolfe G I, Bryan W W et al. Electrophysiologic findings in multifocal motor neuropathy. Neurology. 1997; 48 700-707
- 14 Joint Task Force of the EFNS and the PNS. J Periph Nerv Syst. 2006; 11 9-19
- 15 Olney R K. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve. 1999; 8 S225-S229
- 16 Umapathi T, Hughes R A, Nobile-Orazio E et al. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev. 2009; CD003217
Johannes Bufler
Neurologische Klinik mit klinischer Neurophysiologie, Inn Salzach Klinikum Wasserburg
Postfach 1111
83501 Wasserburg
Email: Johannes.Bufler@iskl.de